ELISA analysis of urinary nephrin and podocalyxin standardized by aquaporin-2 in adult patients with nephrotic syndrome

Journal of Nephrology

Volumn 27, Issue 4, 2014, Pages 411-417

  Zhu, Bin ^a   Li, Xian fa ^a   Zhu, Xiao ling ^a   Lin, Yi ^a   Zhong, Sen ^b   Zhu, Cai feng ^a   Tang, Xuan li ^a   Hu, Yun qing ^a   Cheng, Xiao xia ^a   Wang, Yong jun ^a  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^b THE FIRST PEOPLE S HOSPITAL OF WENLING   (China)

Author keywords

Aquaporin 2; ELISA; Nephrin; Nephrotic syndrome; Podocalyxin; Urinary podocyte

Indexed keywords

AQUAPORIN 2; IMMUNOGLOBULIN M; NEPHRIN; PODOCALYXIN; MEMBRANE PROTEIN; SIALOGLYCOPROTEIN;

ADULT; AMYLOIDOSIS; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULOSCLEROSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; YOUNG ADULT; ADOLESCENT; AGED; CASE CONTROL STUDY; CHILD; CYTOLOGY; GLOMERULONEPHRITIS; LIPOID NEPHROSIS; PATHOLOGY; PODOCYTE; SENSITIVITY AND SPECIFICITY; URINE;

ADOLESCENT; ADULT; AGED; AMYLOIDOSIS; AQUAPORIN 2; CASE-CONTROL STUDIES; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME; PODOCYTES; SENSITIVITY AND SPECIFICITY; SIALOGLYCOPROTEINS; URINE; YOUNG ADULT;

EID: 84904507234     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-014-0066-z     Document Type: Article

References (49)

1. Matsusaka T, Sandgren E, Shintani A, Kon V, Pastan I, Fogo AB et al (2011) Podocyte injury damages other podocytes. J Am Soc Nephrol 22(7): 1275-1285.
2. Jefferson JA, Alpers CE, Shankland SJ (2011) Podocyte biology for the bedside. Am J Kidney Dis 58(5): 835-845.
3. Shimada M, Araya C, Rivard C, Ishimoto T, Johnson RJ, Garin EH (2011) Minimal change disease: a "two-hit" podocyte immune disorder? Pediatr Nephrol 26(4): 645-649.
4. Menzel S, Moeller MJ (2011) Role of the podocyte in proteinuria. Pediatr Nephrol 26(10): 1775-1780.
5. Yin H, Li X, Gong Q, Jin X, Gu H, Yuan B et al (2010) Heme oxygenase-1 upregulation improves lipopolysaccharide-induced acute lung injury involving suppression of macrophage migration inhibitory factor. Mol Immunol 47(15): 2443-2449.
6. Hara M, Yanagihara T, Kihara I (2001) Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron 89(3): 342-347.
7. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Sekizuka K et al (2000) Urinary podocytes for the assessment of disease activity in lupus nephritis. Am J Med Sci 320(2): 112-116.
8. Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I et al (2000) Urinary excretion of podocytes in patients with diabetic nephropathy. Nephrol Dial Transplant 15(9): 1379-1383.
9. Hara M, Yanagihara T, Takada T, Itoh M, Matsuno M, Yamamoto T et al (1998) Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis. Am J Nephrol 18(1): 35-41.
10. Hara M, Yanagihara T, Itoh M, Matsuno M, Kihara I (1998) Immunohistochemical and urinary markers of podocyte injury. Pediatr Nephrol 12(1): 43-48.
11. Hara M, Yamamoto T, Yanagihara T, Takada T, Itoh M, Adachi Y et al (1995) Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis. Nephron 69(4): 397-403.
12. Sato Y, Wharram BL, Lee SK, Wickman L, Goyal M, Venkatareddy M et al (2009) Urine podocyte mRNAs mark progression of renal disease. J Am Soc Nephrol 20(5): 1041-1052.
13. Pang W, Zheng X, Tan Y, Li j (2010) The influence of podocytes detection in urine sampie quantities and storage. Chin J Integr Tradit West Nephrol 12(6): 3.
14. Kanno K, Kawachi H, Uchida Y, Hara M, Shimizu F, Uchiyama M (2003) Urinary sediment podocalyxin in children with glomerular diseases. Nephron Clin Pract 95(3): c91-c99.
15. Walker RJ, Weggery S, Bedford JJ, McDonald FJ, Ellis G, Leader JP (2005) Lithium-induced reduction in urinary concentrating ability and urinary aquaporin 2 (AQP2) excretion in healthy volunteers. Kidney Int 67(1): 291-294.
16. Graffe CC, Bech JN, Pedersen EB (2012) The effect of high and low sodium intake on urinary aquaporin-2 excretion in healthy humans. Am J Physiol Renal Physiol 302(2): F264-F275.
17. M. Brenner B, Levine SA (2008) Brenner and Rector's The kidney, Vol 1. Saunders Elsevier.
18. Helin H, Mustonen J, Pasternack A, Antonen J (1982) IgM-associated glomerulonephritis. Nephron 31(1): 11-16.
19. Hara M, Yamagata K, Tomino Y, Saito A, Hirayama Y, Ogasawara S et al (2012) Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin. Diabetologia 55(11): 2913-2919.
20. Manno C, Strippoli GF, Arnesano L, Bonifati C, Campobasso N, Gesualdo L et al (2004) Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 66(4): 1570-1577.
21. Fogo AB (2011) The targeted podocyte. J Clin Invest 121(6): 2142-2145.
22. Zheng M, Lv LL, Ni J, Ni HF, Li Q, Ma KL et al (2011) Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy. PLoS One 6(5): e20431.
23. Matsusaka T, Kobayashi K, Kon V, Pastan I, Fogo AB, Ichikawa I (2011) Glomerular sclerosis is prevented during urinary tract obstruction due to podocyte protection. Am J Physiol Renal Physiol 300(3): F792-F800.
24. Son GH, Kim JH, Hwang JH, Kim YH, Park YW, Kwon JY (2010) Urinary excretion of nephrin in patients with severe preeclampsia. Hypertens Pregnancy.
25. Camici M (2008) Urinary biomarkers of podocyte injury. Biomark Med 2(6): 613-616.
26. Wang G, Lai FM, Tam LS, Li KM, Lai KB, Chow KM et al (2007) Messenger RNA expression of podocyte-associated molecules in urinary sediment of patients with lupus nephritis. J Rheumatol 34(12): 2358-2364.
27. Wang G, Lai FM, Lai KB, Chow KM, Li KT, Szeto CC (2007) Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy. Nephron Clin Pract 106(4): c169-c179.
28. Camici M (2007) Urinary detection of podocyte injury. Biomed Pharmacother 61(5): 245-249.
29. De Petris L, Patrick J, Christen E, Trachtman H (2006) Urinary podocyte mRNA excretion in children with D + HUS: a potential marker of long-term outcome. Ren Fail 28(6): 475-482.
30. Szeto CC, Lai KB, Chow KM, Szeto CY, Yip TW, Woo KS et al (2005) Messenger RNA expression of glomerular podocyte markers in the urinary sediment of acquired proteinuric diseases. Clin Chim Acta 361(1-2): 182-190.
31. Meyer TW, Bennett PH, Nelson RG (1999) Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria. Diabetologia 42(11): 1341-1344.
32. Cybulsky AV (2011) Membranous nephropathy. Contrib Nephrol 169: 107-25.
33. Cho MH, Hong EH, Lee TH, Ko CW (2007) Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis. Nephrology (Carlton) 12 Suppl 3(S11-4).
34. Nakamura T, Ushiyama C, Shimada N, Sekizuka K, Ebihara I, Hara M et al (2001) Effect of cyclophosphamide or azathioprine on urinary podocytes in patients with diffuse proliferative lupus nephritis. Nephron 87(2): 192-193.
35. Trivedi S, Zeier M, Reiser J (2009) Role of podocytes in lupus nephritis. Nephrol Dial Transplant 24(12): 3607-3612.
36. Xu L, Yang HC, Hao CM, Lin ST, Gu Y, Ma J (2010) Podocyte number predicts progression of proteinuria in IgA nephropathy. Mod Pathol 23(9): 1241-1250.
37. Roufosse CA, Cook HT (2009) Pathological predictors of prognosis in immunoglobulin A nephropathy: a review. Curr Opin Nephrol Hypertens 18(3): 212-219.
38. Lai KN, Leung JC, Chan LY, Saleem MA, Mathieson PW, Tam KY et al (2009) Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. Nephrol Dial Transplant 24(1): 62-72.
39. Hishiki T, Shirato I, Takahashi Y, Funabiki K, Horikoshi S, Tomino Y (2001) Podocyte injury predicts prognosis in patients with iga nephropathy using a small amount of renal biopsy tissue. Kidney Blood Press Res 24(2): 99-104.
40. Cook HT (2011) Focal segmental glomerulosclerosis in IgA nephropathy: a result of primary podocyte injury? Kidney Int 79(6): 581-583.
41. Sharma SG, Spencer T, Gokden N (2010) The significance of foot process effacement in immunoglobulin a nephropathy: clinicopathologic study of 161 cases with light, immunofluorescence and electron microscopic studies. Ultrastruct Pathol 34(5): 269-272.
42. Hara M, Yanagihara T, Kihara I (2007) Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schonlein-Henoch purpura nephritis. Clin J Am Soc Nephrol 2(2): 231-238.
43. Lemley KV, Lafayette RA, Safai M, Derby G, Blouch K, Squarer A et al (2002) Podocytopenia and disease severity in IgA nephropathy. Kidney Int 61(4): 1475-1485.
44. Myllymaki J, Saha H, Mustonen J, Helin H, Pasternack A (2003) IgM nephropathy: clinical picture and long-term prognosis. Am J Kidney Dis 41(2): 343-350.
45. Bhowmik D, Chitale A, Bulchand S (2007) IgM nephropathy in adults: incidence and correlation with electron microscopic features. Indian J Pathol Microbiol 50(3): 511-514.
46. Gubler MC, Naizot C (1987) Renal amyloidosis in children: an ultrastructural study. Appl Pathol 5(2): 116-120.
47. Dikman SH, Churg J, Kahn T (1981) Morphologic and clinical correlates in renal amyloidosis. Hum Pathol 12(2): 160-169.
48. von Gise H, Helmchen U, Mikeler E, Bruning L, Walther C, Christ H et al (1978) Correlations between the morphological and clinical findings in a patient recovering from secondary generalized amyloidosis with renal involvement. Light and electron microscopic investigations on serial biopsies. Virchows Arch A Pathol Anat Histol 379(2): 119-129.
49. Hetzel GR, Uhlig K, Mondry A, Helmchen U, Grabensee B (2000) AL-amyloidosis of the kidney initially presenting as minimal change glomerulonephritis. Am J Kidney Dis 36(3): 630-635.